Home > Analytics > GODAVARI DRUGS

GODAVARI DRUGS
Intrinsic Value | Fundamental Analysis

BOM : 530317     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
Sep 28,2022
Price(EOD): ₹ 65.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 49.28 Cr
Value of ₹ 1 Lac invested in GODAVARI DRUGS
on Sep 28,2017 (price: ₹ 33.90)

₹ 1 L

₹ 1.94 L

1W : -2.9% 1M : -6.3% 1Y : -3%
COMMUNITY POLL
for GODAVARI DRUGS
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
GODAVARI DRUGS -2.9% -6.3% -3%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 4.6% 16.5%
DIVIS LABORATORIES 3.5% 3.4% -28.5%
DR REDDYS LABORATORIES 2% 1.4% -13.7%
CIPLA 3.3% 7.9% 13.9%
GLAND PHARMA -5.7% -12.4% -46.5%
PIRAMAL ENTERPRISES -12.6% -55.9% -68.4%
CADILA HEALTHCARE 1.6% -2.3% -36.2%
TORRENT PHARMACEUTICALS -2.9% -3% -1.1%

FUNDAMENTAL ANALYSIS OF GODAVARI DRUGS

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF GODAVARI DRUGS

 
Valuation Score
[As on : Sep 28,2022 ]

Ratio Standalone
P/E
P/B
P/S
10.44
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 4.74 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

1.67
P/B Calculated based on Book Value of Rs 29.63 Cr
[Latest Year - Mar2022 - Standalone Results ]

0.31
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF GODAVARI DRUGS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
142%
-24%
-16%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF GODAVARI DRUGS



GODAVARI DRUGS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF GODAVARI DRUGS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.78
1.25
1.36
1.13
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF GODAVARI DRUGS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF GODAVARI DRUGS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-3.91%
-11.21%
-29.01%
-27.31%
-4.17%
-22.45%
-36.18%
-35.28%
QtrlyTrend
-8
Latest Qtr: Jun2022
Quarterly Result Analysis →


GODAVARI DRUGS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about GODAVARI DRUGS


Is GODAVARI DRUGS good for long term investment?

As on Sep 28,2022, the Fundamentals of GODAVARI DRUGS look Poor and hence it may not be good for long term investment ! See Financial Performance of GODAVARI DRUGS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is GODAVARI DRUGS UnderValued or OverValued?

As on Sep 28,2022, GODAVARI DRUGS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of GODAVARI DRUGS ?

As on Sep 28,2022, the Intrinsic Value of GODAVARI DRUGS is Rs. 78.57 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 27.17
Fair Value [Median EV / Sales Model] : Rs. 85.96
Fair Value [Median Price / Sales Model] : Rs. 78.57
Estimated Median Fair Value of GODAVARI DRUGS : Rs. 78.57

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is GODAVARI DRUGS trading at a Premium or Discount?

As on Sep 28,2022, GODAVARI DRUGS is trading at a Discount of -16% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].